References

Abbey, David E., Bessie L. Hwang, Raoul J. Burchette, Tony Vancuran, et al. 1995. Estimated Long-Term Ambient Concentrations of PM10 and Development of Respiratory Symptoms in a Nonsmoking Population. Archives of Environmental Health 50(2):139–152.

Adler, Matthew D. 2003. Risk, Death and Harm: The Normative Foundations of Risk Regulation. Minnesota Law Review 87:1293–1418.

Adler, Matthew D. 2005. QALYs and Policy Evaluation: A New Perspective. Working Paper 05-01. Washington, DC: AEI-Brookings Joint Center.

Agency for Healthcare Research and Quality (AHRQ). 2005. The Guide to Clinical Preventive Services, 2005: Recommendations of the U.S. Preventive Services Task Force. Rockville, MD: AHRQ.

Anderson, John R., Robert M. Kaplan, and Christopher F. Ake. 2004. Arthritis Impact on U.S. Life Quality: Morbidity and Mortality Effects From National Health Interview Survey Data 1986–1988 and 1994 Using QWBX1 Estimates of Well-Being. Social Indicators Research 69:67–91.

Anderson, Roger T., Mary McFarlane, Michelle J. Naughton, and Sally A. Shumaker. 1996. Conceptual Issues and Considerations in Cross-Cultural Validation of Generic Health-Related Quality of Life Instruments. In: Spilker, Bert, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers. Pp. 605–612.

Andresen, Elena M., Barbara M. Rothenberg, and Robert M. Kaplan. 1998. Performance of a Self-Administered Mailed Version of the Quality of Well-Being (QWB-SA) Questionnaire Among Older Adults. Medical Care 36(9):1349–1360.

Arrow, Kenneth, P.R. Solow, E.E. Portney, R. Leamer, et al. 1993. Report of the NOAA Panel on Contingent Valuation. Federal Register 58(10):4601–4614.

Ashford, Nicholas A. 1980. The Limits of Cost–Benefit Analysis in Regulatory Decisions. Technology Review 82(6):70–72.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis References Abbey, David E., Bessie L. Hwang, Raoul J. Burchette, Tony Vancuran, et al. 1995. Estimated Long-Term Ambient Concentrations of PM10 and Development of Respiratory Symptoms in a Nonsmoking Population. Archives of Environmental Health 50(2):139–152. Adler, Matthew D. 2003. Risk, Death and Harm: The Normative Foundations of Risk Regulation. Minnesota Law Review 87:1293–1418. Adler, Matthew D. 2005. QALYs and Policy Evaluation: A New Perspective. Working Paper 05-01. Washington, DC: AEI-Brookings Joint Center. Agency for Healthcare Research and Quality (AHRQ). 2005. The Guide to Clinical Preventive Services, 2005: Recommendations of the U.S. Preventive Services Task Force. Rockville, MD: AHRQ. Anderson, John R., Robert M. Kaplan, and Christopher F. Ake. 2004. Arthritis Impact on U.S. Life Quality: Morbidity and Mortality Effects From National Health Interview Survey Data 1986–1988 and 1994 Using QWBX1 Estimates of Well-Being. Social Indicators Research 69:67–91. Anderson, Roger T., Mary McFarlane, Michelle J. Naughton, and Sally A. Shumaker. 1996. Conceptual Issues and Considerations in Cross-Cultural Validation of Generic Health-Related Quality of Life Instruments. In: Spilker, Bert, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers. Pp. 605–612. Andresen, Elena M., Barbara M. Rothenberg, and Robert M. Kaplan. 1998. Performance of a Self-Administered Mailed Version of the Quality of Well-Being (QWB-SA) Questionnaire Among Older Adults. Medical Care 36(9):1349–1360. Arrow, Kenneth, P.R. Solow, E.E. Portney, R. Leamer, et al. 1993. Report of the NOAA Panel on Contingent Valuation. Federal Register 58(10):4601–4614. Ashford, Nicholas A. 1980. The Limits of Cost–Benefit Analysis in Regulatory Decisions. Technology Review 82(6):70–72.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Bakker, C., M. Rutten, E. van Doorslaer, K. Bennett, et al. 1994. Feasibility of Utility Assessment by Rating Scale and Standard Gamble in Patients With Ankylosing Spondylitis and Fibromyalgia. Journal of Rheumatology 21:269–274. Balaban, D.J., P.C. Sagi, N.I. Goldfarb, and S. Nettler. 1986. Weights for Scoring the Quality of Well-Being Instrument Among Rheumatoid Arthritics: A Comparison to the General Population Weights. Medical Care 24:973–980. Bedford, Tim, and Roger M. Cooke. 2001. Probabilistic Risk Analysis. New York: Cambridge University Press. Bell, Chaim M., Richard H. Chapman, Patricia W. Stone, Eileen A. Sandberg, and Peter J. Neumann. 2001. An Off-the-Shelf Help List: A Comprehensive Catalog of Preference Scores From Published Cost-Utility Analyses. Medical Decision Making 21(4):288–294. Bleichrodt, Han, and Magnus Johannesson. 1997. Standard Gamble, Time Trade-Off and Rating Scale: Experimental Results on the Ranking Properties of QALYs. Journal of Health Economics 16(2):155–175. Bleichrodt, Han, Jose L. Pinto, and Peter P. Wakker. 2001. Making Descriptive Use of Prospect Theory to Improve the Prescriptive Use of Expected Utility. Management Science 47(11):1498–1514. Bleichrodt, Han, Jose L. Pinto, and Jose M. Abellan-Perpinan. 2003. A Consistency Test of the Time Trade-Off. Journal of Health Economics 22:1037–1052. Boyle, M.H., G.W. Torrance, J.C. Sinclair, and S.P. Horwood. 1983. Economic Evaluation of Neonatal Intensive Care of Very Low-Birthweight Infants. New England Journal of Medicine 308(22):1330–1337. Brauer, Carmen, and Peter Neumann. 2004. A Catalogue of Preference Weights Used in Published Cost–Utility Analyses, 1998–2001. Prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. ———. 2005. Using an Online Catalog of Utility Scores From Published Cost–Utility Analyses to Estimate Quality of Life Impacts in the EPA Case Study. Prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Brazier, John, Mark Deverill, C. Green, R. Harper, and A. Booth. 1999a. A Review of the Use of Health Status Measures in Economic Evaluation. Health Technology Assessment 3(9):1–164. Brazier, John, Mark Deverill, and Colin Green. 1999b. A Review of the Use of Health Status Measures in Economic Evaluation. Journal of Health Services Research and Policy 4(3):174–184. Brazier, John, Jennifer Roberts, and Mark Deverill. 2002. The Estimation of a Preference-Based Measure of Health From the SF-36. Journal of Health Economics 21:271–292. Brazier, John E., and Jennifer Roberts. 2004. The Estimation of a Preference-Based Measure of Health From the SF-12. Medical Care 42(9):851–859. Brazier, John E., T.P. Usherwood, R. Harper, and K. Thomas. 1998. Deriving a Preference Based Single Index From the UK SF-36 Health Survey. Journal of Clinical Epidemiology 51(11):1115–1129. Briggs, Andrew. 2001. Handling Uncertainty in Economic Evaluation and Presenting the Results. In: Drummond, Michael, and McGuire, Alistair, eds. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press. Pp. 172–214. Briggs, Andrew H., Ron Goeree, Gord Blackhouse, and Bernie J. O’Brien. 2002. Probabilistic Analysis of Cost-Effectiveness Models: Choosing Between Treatment Strategies for Gastroesophageal Reflux Disease. Medical Decision Making 22(4):290–308.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Bush, J.W., M.M. Chen, and D.L. Patrick. 1973. Health Status Index in Cost Effectiveness: Analysis of PKU Program. In: Berg, Richard L., ed. Health Status Indexes. Chicago: Hospital Research and Educational Trust. Pp. 172–208. Carter, Jimmy. 1978, March 23. Improving Government Regulations, Executive Order 12044. White House. Centers for Disease Control and Prevention (CDC). 2002. United States Life Tables, 2000. National Vital Statistics Reports 51(3). ———. 2005. 2004 Behavioral Risk Factor Surveillance System Summary Data Quality Report. [Online]. Available: http://www.cdc.gov/brfss/technical_infodata/surveydata/2004.htm [accessed September 5, 2005]. Chapman, Richard H., Patricia W. Stone, Eileen A. Sandberg, Chaim Bell, and Peter J. Neumann. 2000. A Comprehensive League Table of Cost-Utility Ratios and a Sub-Table of “Panel-Worthy” Studies. Medical Decision Making 20:451–467. Chapman, Richard H., Marc Berger, Milton C. Weinstein, Jane C. Weeks, et al. 2004. When Does Quality-Adjusting Life-Years Matter in Cost-Effectiveness Analysis? Health Economics 13:429–436. Chiang, C.L. 1965. An Index of Health: Mathematical Models. Public Health Services Publication. Washington, DC: National Center for Health Statistics. Churchill, D.N., G.W. Torrance, D.W. Taylor, C.G. Barnes, et al. 1987. Measurement of Quality of Life in End-Stage Renal Disease: The Time Trade-Off Approach. Clinical and Investigative Medicine 10:14–20. Claxton, Karl, Mark Sculpher, Chris McCabe, Andrew Briggs, et al. 2005. Probabilistic Sensitivity Analysis for NICE Technology Assessment: Not an Optional Extra. Health Economics 14(4):339–347. Cranor, Carl F. 1995. The Use of Comparative Risk Judgments in Risk Management. In: Fan, A.M., and Chang, L.W., eds. Toxicology and Risk Assessment: Principles, Methods, and Applications. Marcel Dekker, Inc. Pp. 817–833. Cropper, Maureen L., Sema K. Aydede, and Paul R. Portney. 1994. Preferences for Life Saving Programs: How the Public Discounts Time and Age. Journal of Risk and Uncertainty 8:243–265. Culyer, A.J. 1991. The Normative Economics of Health Care Finance and Provision. In: McGuire, Alistair, Fenn, Paul, and Mayhew, Ken, eds. Providing Health Care: The Economics of Alternative Systems of Finance and Delivery . Oxford: Oxford University Press. Pp. 65–98. Cutler, David M., and Elizabeth Richardson. 1997. Measuring the Health of the United States Population. Brookings Papers on Economic Activity. Microeconomics 217–271. ———. 1999. Your Money and Your Life; The Value of Health and What Affects It. In: Garber, Alan M., ed. Frontiers in Health Policy Research 2. Cambridge, MA: MIT Press. Pp. 99–132. Daniels, Norman, and James E. Sabin. 1997. Limits to Health Care: Fair Procedures, Democratic Deliberation, and the Legitimacy Problem for Insurers. Philosophy and Public Affairs 4:303–350. ———. 2002. Setting Limits Fairly: Can We Learn to Share Medical Resources? Oxford: Oxford University Press. de Hollander, Augustinus E.M., Johan M. Melse, Erik Lebret, and Pieter G.N. Kramers. 1999. An Aggregate Public Health Indicator to Represent the Impact of Multiple Environmental Exposures. Epidemiology 10(5):606–617. Desvousges, William H., F. Reed Johnson, and H. Spencer Banzhaf. 1998. Environmental Policy Analysis with Limited Information: Principles and Application of the Transfer Method. Northampton, MA: Edward Elgar.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Dolan, Paul. 1997. Modeling Valuations for EuroQol Health States. Medical Care 35(11):1095–1108. ———. 2000. The Measurement of Health-Related Quality of Life for Use in Resource Allocation Decisions in Health Care. In: Culyer, Anthony J., and Newhouse, Joseph P., eds. Handbook of Health Economics. Vol. 1B. Amsterdam: Elsevier. Pp. 1724–1760. Dolan, Paul, and Richard Edlin. 2002. Is It Really Possible to Build a Bridge Between Cost–Benefit Analysis and Cost-Effectiveness Analysis? Journal of Health Economics 21(5): 827–843. Dolan, Paul, and Colin Green. 1998. Using the Person Trade-Off Approach to Examine Differences Between Individual and Social Values. Health Economics 7:307–312. Dolan, Paul, and Claire Gudex. 1995. Time Preference, Duration and Health State Valuations. Health Economics 4:289–299. Dolan, Paul, and Jennifer Roberts. 2002. Modelling Valuations for EQ-5D Health States: An Alternative Modeling Using Differences in Valuations. Medical Care 40(5):442–446. Dolan, Paul, Claire Gudex, Paul Kind, and Alan Williams. 1996a. Valuing Health States: A Comparison of Methods. Journal of Health Economics 15(2):209–231. ———. 1996b. The Time Trade-Off Method: Results From A General Population Study. Health Economics 5:141–154. Drummond, Michael F., Bernie J. O’Brien, Greg L. Stoddart, and George W. Torrance. 1997. Methods for the Economic Evaluation of Health Programmes. Oxford: Oxford University Press. Eiser, C., and R. Morse. 2001a. Quality-of-Life Measures in Chronic Diseases of Childhood. Health Technology Assessment 5(4):1–157. ———. 2001b. A Review of Measures of Quality of Life for Children With Chronic Illness. Archives of Disease in Childhood 84(3):205–211. Fanshel, S., and J. Bush. 1970. A Health Status Index and Its Application to Health Services Outcomes. Operations Research 18(6):1021–1066. Feeny, David, William Furlong, Michael Boyle, and George W. Torrance. 1995. Multi-Attribute Health Status Classification Systems. Pharmacoeconomics 7(6):490–502. Feeny, David, William Furlong, George W. Torrance, Charles H. Goldsmith, et al. 2002. Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System. Medical Care 40(2):113–128. Feeny, David H., George W. Torrance, and William J. Furlong. 1996. Health Utilities Index. In: Spilker, B., ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers. Pp. 239–252. Fenwick, Elisabeth, Bernie J. O’Brien, and Andrew Briggs. 2004. Cost-Effectiveness Acceptability Curves—Facts, Fallacies and Frequently Asked Questions. Health Economics 13:405–415. Fischhoff, Baruch. 1991. Value Elicitation: Is There Anything in There? American Psychologist 46(8):835–847. Fleishman, John, and William Lawrence. 2004 (December 1). Health Status Measures in the Medical Expenditure Panel Survey. Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Fox-Rushby, J.F., and K. Hanson. 2001. How to Do (Or Not to Do) … Calculating and Presenting Disability Adjusted Life Years (DALYs) in Cost-Effectiveness Analysis. Health Policy and Planning 16(3):326–331. Frankel, H.L., J.R. Coll, S.W. Charlifue, G.C. Whiteneck, et al. 1998. Long-Term Survival in Spinal Cord Injury: A Fifty Year Investigation. Spinal Cord 36:266–274.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Franks, Peter. 2004 (November 30). Towards Consistency in Cost-Effectiveness Analysis. Measuring Health Status: Tower of Babel or Glass Half Full … And Can We Do Better? Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Franks, Peter, Erica I. Lubetkin, Marthe R. Gold, and Daniel J. Tancredi. 2003. Mapping the SF-12 to Preference-Based Instruments: Convergent Validity in a Low-Income Minority Population. Medical Care 41(11):1277–1283. Franks, Peter, E.I. Lubetkin, M.R. Gold, D.J. Tancredi, and H. Jia. 2004. Mapping the SF-12 to the EuroQol EQ-5D Index in a National US Sample. Medical Decision Making 24(3):247–254. Franks, Peter, Janel Hanmer, and Dennis Fryback. 2006. Relative Disutilities of 47 Risk Factors and Conditions Assessed With 7 Preference-Based Health Status Measures in a National U.S. Sample: Toward Consistency in Cost-Effectiveness Analysis. Forthcoming in Medical Care. Freeman, A.M. 2003. The Measurement of Environmental and Resource Value: Theory and Methods. 2nd ed. Washington, DC: Resources for the Future. Froberg, Debra G., and Robert L. Kane. 1989. Methodology for Measuring Health-State Preferences-II: Scaling Methods. Journal of Clinical Epidemiology 42(5):459–471. Fryback, Dennis. 2003. Understanding and Comparing Existing Summary Measures of Health and Health-Related Quality of Life. Madison, WI: University of Wisconsin–Madison. Fryback, Dennis G., and William F. Lawrence. 1997. Dollars May Not Buy as Many QALYs as We Think: A Problem with Defining Quality-of-Life Adjustments. Medical Decision Making 17:276–284. Fryback, Dennis G., Erik J. Dasbach, Ronald Klein, Barbara E. Klein, et al. 1993. The Beaver Dam Health Outcomes Study: Initial Catalog of Health-State Quality Factors. Medical Decision Making 13(2):89–102. Gabriel, S.E., M.E. Camion, and W.M. O’Fallon. 1993. Patient Preferences for Nonsteroidal Antiinflammatory Drug Related Gastrointestinal Complication and Their Prophylaxis. Journal of Rheumatology 20:358–361. Gafni, Amiram. 2004 (November 30). HYEs and QALYs: Spotting the Differences. Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Gilbert, Daniel T., and Jane E.J. Ebert. 2002. Decisions and Revisions: The Affective Forecasting of Changeable Outcomes. Journal of Personality and Social Psychology 82(4): 503–514. Gilliland, F.D., R. McConnell, J. Peters, and H. Gong, Jr. 1999. A Theoretical Basis for Investigating Ambient Air Pollution and Children’s Respiratory Health. Environmental Health Perspectives 107(Suppl 3):403–407. Gold, Marthe, Peter Franks, and Pennifer Erickson. 1996a. Assessing the Health of the Nation: The Predictive Validity of a Preference-Based Measure and Self-Rated Health. Medical Care 34(2):163–177. Gold, Marthe R., Joanna E. Siegel, Louise B. Russell, and Milton C. Weinstein, eds. 1996b. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. Gold, Marthe R., Peter Franks, Kristine I. McCoy, and Dennis G. Fryback. 1998. Towards Consistency in Cost-Utility Analyses: Using National Measures to Create Condition-Specific Values. Medical Care 36(6):778–792. Gold, Marthe, David Stevenson, and Dennis G. Fryback. 2002. HALYs and QALYs and DALYs, Oh My: Similarities and Differences in Summary Measures of Population Health. Annual Review of Public Health 23:115–134.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Graham, John D. 2003a (May 30). Memorandum to the President’s Management Council: Benefit-Cost Methods and Life Saving Rules. [Online]. Available: http://www.whitehouse.gov/OMB/inforeg/pmc_benefit_cost_memo.pdf [accessed January 3, 2006]. Graham, John D. 2003b. Valuing Health: An OMB Perspective. Remarks Prepared for Conference on Valuing Health Outcomes: An Assessment of Approaches. Washington, DC: Resources for the Future. Graham, John D., and Jonathan B. Wiener. 1995. Risk vs Risk. Cambridge, MA: Harvard University Press. Green, Colin. 2001. On the Societal Value of Health Care: What Do We Know About the Person Trade-Off Technique? Health Economics 10:233–243. Greenberg, Dan, and Joseph S. Pliskin. 2002. Preference-Based Outcome Measures in Cost-Utility Analyses. International Journal of Technology Assessment in Health Care 18(3): 461–466. Griebsch, Ingolf, Joanna Coast, and Jackie Brown. 2005. Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility in Child Health. Pediatrics 115(5):e600–e614. Gudex, Claire, Paul Dolan, Paul Kind, and Alan Williams. 1996. Health State Valuations From the General Public Using the Visual Analogue Scale. Quality of Life Research 5(6):521–531. Haffer, Samuel. 2004 (December 1). Comparison of Major CMS Surveys Collecting Functional Status Information. Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Hahn, Robert W. 2005. In Defense of the Economic Analysis of Regulation. Washington, DC: AEI-Brookings Joint Center for Regulatory Studies. Hammitt, James K. 2002. QALYs Versus WTP. Risk Analysis 22(5):985–1001. Hanmer, Janel, William F. Lawrence, John P. Anderson, Robert M. Kaplan, et al. 2006. Report of Nationally Representative Values for the Non-Institutionalized U.S. Adult Population for Seven Health Related Quality of Life Scores. Forthcoming in Medical Decision Making. Harrington, Winston, Richard D. Morgenstern, and Peter Nelson. 2000. On the Accuracy of Regulatory Cost Estimates. Journal of Policy Analysis and Management 19(2):297–322. Harris, John. 1987. QALYfying the Value of Life. Journal of Medical Ethics 13(3):117–123. Harrison-Felix, Cynthia, Gale Whiteneck, Michael DeVivo, Flora M. Hammond, and Amitabh Jha. 2004. Mortality Following Rehabilitation in the Traumatic Brain Injury Model Systems of Care. NeuroRehabilitation 19:45–54. Harvard Center for Risk Analysis. 2003. The CEA Registry. [Online]. Available: http://www.hsph.harvard.edu/cearegistry [accessed September 20, 2005]. Hausman, Daniel M. 2004 (November 30). Evaluating Health Consequences: HALYs vs. WTP. Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Hawthorne, Graeme, Jeff Richardson, and Neal A. Day. 2001. A Comparison of the Assessment of Quality of Life (AQoL) With Four Other Generic Utility Instruments. Annals of Medicine 33(5):358–370. Heitjan, Daniel F. 2000. Fieller’s Method and Net Health Benefits. Health Economics 9:327–335. Hennessy, Sue, and Paul Kind. 2002. Measuring Health Status in Children: Developing and Testing a Child-Friendly Version of EQ-5D. [Online]. Available: http://www.euroqol.org/meetings/meeting2002/Chap21.pdf [accessed August 15, 2005]. Hicks, John R. 1939. Value and Capital: An Inquiry to Some Fundamental Principles of Economic Theory. Oxford: Oxford University Press.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Hirth, Richard A., Michael E. Chernew, Edward Miller, A.M. Fendrick, and William G. Weissert. 2000. Willingness to Pay for a Quality-Adjusted Life Year: In Search of a Standard. Medical Decision Making 20:332–342. Holbrook, Troy L., John P. Anderson, William J. Sieber, Deirdre Browner, and David B. Hoyt. 1999. Outcome After Major Trauma: 12-Month and 18-Month Follow-Up Results From the Trauma Recovery Project. Journal of Trauma Injury, Infection, and Critical Care 46(5):765–773. Houle, Christian, and Jean-Marie Berthelot. 2000. A Head-to-Head Comparison of the Health Utilities Index Mark 3 and the EQ-5D for the Population Living in Private Households in Canada. Quality of Life Newsletter 24:5–6. Hubbell, Bryan J. 2004. Health Based Cost Effectiveness of Ambient PM Reductions. Unpublished draft paper. Raleigh-Durham, NC: Environmental Protection Agency. Hubbell, Bryan J., Aaron Hallberg, Donald R. McCubbin, and Ellen Post. 2005. Health-Related Benefits of Attaining the 8-Hour Ozone Standard. Environmental Health Perspectives 113(1):73–82. Hunink, Myriam, Paul P. Glasziou, Joanna E. Siegel, Jane C. Weeks, et al. 2001. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge: Cambridge University Press. Hurley, Jeremiah. 2000. An Overview of the Normative Economics of the Health Sector. In: Culyer, A.J., and Newhouse, Joseph P., eds. Handbook of Health Economics. New York: Elsevier Science. Pp. 56–110. Institute of Medicine. 1997. Enabling America: Assessing the Role of Rehabilitation Science and Engineering. Washington, DC: National Academy Press. ———. 1998. Summarizing Population Health: Directions for the Development and Application of Population Metrics. Washington, DC: National Academy Press. ———. 2005. Estimating the Contributions of Lifestyle-Related Factors to Preventable Death: A Workshop Summary. Washington, DC: National Academies Press. Jacobson, Peter D., and Richard E. Hoffman. 2003. Regulating Public Health: Principles and Applications of Administrative Law. In: Goodman, Richard A., et al., eds. Law in Public Health Practice. New York: Oxford University Press. Pp. 23–42. Jacobson, Peter D., and Matthew L. Kanna. 2001. Cost-Effectiveness Analysis in the Courts: Recent Trends and Future Prospects. Journal of Health Politics, Policy and Law 26:291–326. Johannesson, Magnus. 2001. Should We Aggregate Relative or Absolute Changes in QALYs? Health Economics 10:537–577. Johannesson, Magnus, Joseph S. Pliskin, and Milton C. Weinstein. 1994. A Note on QALYs, Time Tradeoff, and Discounting. Medical Decision Making 14:189–193. Johnson, F. Reed, Erin E. Fries, and H. Spencer Banzhaf. 1997. Valuing Morbidity: An Integration of the Willingness-to-Pay and Health-Status Index Literatures. Journal of Health Economics 16:641–665. Johnson, F. Reed, H. Spencer Banzhaf, William H. Desvousges. 2000. Willingness to pay for improved respiratory and cardiovascular health: A multiple-format stated-preference approach. Health Economics 9:295–317. Johnson, Jeffrey A., Nan Luo, James W. Shaw, Paul Kind, et al. 2005. Valuations of EQ-5D Health States: Are the United States and United Kingdom Different? Medical Care 43(3):221–228. Jones-Lee, M.W., ed. 1992. Paternalistic Altruism and the Value of Statistical Life. Economic Journal 102:80–90. Juniper, E.F., G.H. Guyatt, D.H. Feeny, L.E. Griffith, et al. 1997. Minimum Skills Required by Children to Complete Health-Related Quality of Life Instruments for Asthma: Comparison of Measurement Properties. European Respiratory Journal 10(10):2285–2294.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Just, Richard E., Darrell L. Hueth, and Andrew Schmitz. 2004. The Welfare Economics of Public Policy: A Practical Approach to Project and Policy Evaluation. Northhampton, MA: Edward Elgar. Kahneman, Daniel, and Amos Tversky, eds. 1979. Prospect Theory: An Analysis of Decision Under Risk. Econometrica 47(2):263–292. ———. 2000. Choices, Values and Frames. Cambridge: Cambridge University Press. Kahneman, Daniel, Peter P. Wakker, and Rakesh Sarin. 1997. Back to Bentham? Explorations of Experienced Utility. Quarterly Journal of Economics 112(2):375–405. Kaldor, Nicholas. 1939. Welfare Propositions of Economics and Interpersonal Comparisons of Utility. Economic Journal 49(196):549–552. Kaplan, Robert M., and John P. Anderson. 1988. A General Health Policy Model: Update and Applications. Health Service Research 23(2):203–235. ———. 1996. The General Health Policy Model: An Integrated Approach. In: Spilker, Bert, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers. Pp. 309–322. Kaplan, Robert M., and James W. Bush. 1982. Health-Related Quality of Life Measurement for Evaluation Research and Policy Analysis. Health Psychology 1(1):61–80. Kaplan, Robert M., J.W. Bush, and Charles C. Berry. 1976. Health Status: Types of Validity and the Index of Well-Being. Health Services Research 11(4):478–507. Kaplan, Robert M., D. Feeny, and D.A. Revicki. 1993. Methods for Assessing Relative Importance in Preference Based Outcome Measures. Quality of Life Research 2:467–475. Kaplan, Robert M., William J. Sieber, and Theodore G. Ganiatas. 1997. The Quality of Well-Being Scale: Comparison of the Interviewer-Administered Version With a Self-Administered Questionnaire. Psychology and Health 12:783–791. Keeler, Emmett B., and Shan Cretin. 1983. Discounting of Life-Saving and Other Nonmonetary Effects. Management Science 29(3):300–306. Keeney, Ralph L., and Howard Raiffa. 1976. Decision With Multiple Objectives: Preferences and Value Tradeoffs. New York: John Wiley and Sons. Keeney, Ralph L., and Detlof von Winterfeldt. 1991. Eliciting Probabilities From Experts in Complex Technical Problems. IEEE Transactions on Engineering Management 38:191–201. Kind, Paul. 2004 (November 30). Issues in the Measurement and Valuation of Health. Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Kind, Paul, Paul Dolan, Clair Gudex, and Alan Williams. 1998. Variations in Population Health Status: Results from a United Kingdom National Questionnaire Survey. British Medical Journal 316(7133):736–741. Kopec, Jacek A., and Kevin D. Willison. 2003. A Comparative Review of Four Preference-Weighted Measures of Health-Related Quality of Life. Journal of Clinical Epidemiology 56:317–325. Kopp, Raymond, Alan J. Krupnick, and Michael Toman. 1997. Cost Benefit Analysis and Regulatory Reform: An Assessment of the Science and the Art. Human and Ecological Risk Assessment 3(5):787–852. Krabbe, Paul F.M., Marie-Louise Essink-Bot, and Gouke J. Bonsel. 1997. The Comparability and Reliability of Five Health-State Valuation Methods. Social Science and Medicine 45(11):1641–1652. Krupnick, Alan K. 2004. Valuing Health Outcomes: Policy Choices and Technical Issues. Washington, DC: Resources for the Future. Landgraf, Jeanne M., and Linda N. Abetz. 1996. Measuring Health Outcomes in Pediatric Populations: Issues in Psychometrics and Application. In: Spilker, Bert, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers. Pp. 793–802.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Laufer, Franklin. 2005. Thresholds in Cost-Effectiveness Analysis—More of the Story. Value in Health 8(1):86–87. Lave, L.B. 1996. Benefit–Cost Analysis: Do the Benefits Exceed the Costs? In: Hahn, R.W., ed. Risks, Costs, and Lives Saved. New York: Oxford University Press. Pp. 104–134. Lawrence, William F., and John A. Fleishman. 2004. Predicting EuroQol EQ-5D Preference Scores From the SF-12 Health Survey in a Nationally Representative Sample. Medical Decision Making 24:160–169. Lenert, Leslie, and Robert M. Kaplan. 2000. Validity and Interpretation of Preference-Based Measures of Health-Related Quality of Life. Medical Care 38(9 Suppl II):II-138–II-150. Lind, Richard C. 1982. A Primer on the Major Issues Relating to the Discount Rate for Evaluating National Energy Options. In: Lind, Richard C., et al. Discounting for Time and Risks in Energy Policy. Washington, DC: Resources for the Future. Llewellyn-Thomas, Hilary A., Heather J. Sutherland, R. Tibshirani, A. Ciampi, et al. 1982. The Measurement of Patients’ Value in Medicine. Medical Decision Making 2(4):449–462. Llewellyn-Thomas, Hilary A., Heather J. Sutherland, and Elaine C. Thiel. 1993. Do Patients’ Evaluations of a Future Health State Change When They Actually Enter That State? Medical Care 31(11):1002–1012. Lohr, Kathleen N., Neil K. Aaronson, Jordi Alonso, Audrey Burnam, et al. 1996. Evaluating Quality-of-Life and Health Status Instruments: Development of Scientific Review Criteria. Clinical Therapeutics 18(5):979–992. Loomes, Graham, and Lynda McKenzie. 1989. The Use of QALYs in Health Care Decision Making. Social Science and Medicine 28(4):299–308. Luo, Nan, Jeffrey A. Johnson, James W. Shaw, David Feeny, et al. 2005. Self-Reported Health Status of the General Adult U.S. Population As Assessed by the EQ-5D and Health Utilities Index. Medical Care 43(11):1078–1086. MacKenzie, Ellen J., Anne Damiano, Ted Miller, and Steve Luchter. 1996. The Development of the Functional Capacity Index. Journal of Trauma 41(5):799–807. MacKenzie, Ellen J., Maria Segui-Gomez, Ted Miller, Anne Damiano, et al. 2004. The Functional Capacity Index. Presentation prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Magaziner, Jay, Eleanor Simonsick, T.M. Kashner, and J.R. Hebel. 1988. Patient-Proxy Response Comparability on Measures of Patient Health and Functional Status. Journal of Clinical Epidemiology 41(11):1065–1074. Manning, Willard G., D.G. Fryback, and M.C. Weinstein. 1996. Reflecting Uncertainty in Cost-Effectiveness Analysis. In: Gold, Marthe R., Siegel, Joanna E., Russell, Louise B., and Weinstein, Milton C., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. Pp. 247–275. Margolis, Howard. 1996. Dealing with Risk: Why the Public and the Experts Disagree on Environmental Issues. Chicago: University of Chicago Press. Mason, Bryce. 2005. Statistical Analysis of Expert Ratings on Health-Related Quality of Life (HRQL) Metrics. Memorandum prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Mathers, Colin D., Christina Bernard, Kim M. Iburg, Mie Inoue, et al. 2003. The Global Burden of Disease in 2002: Data Sources, Methods and Results. Geneva, World Health Organization(GPE Discussion Paper No. 54). [Online]. Available: http://www.who.org/int/evidence [accessed August 10, 2005]. Matza, Louis S., Andrine R. Swensen, Emuella M. Flood, Kristina Secnik, et al. 2004. Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues. Value in Health 7(1):79–92. McDowell, Ian, and Claire Newell. 1996. Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis McNeil, Barbara J., Ralph Weichselbaum, and Stephen G. Pauker. 1978. Fallacy of the Five-Year Survival in Lung Cancer. New England Journal of Medicine 299:1397–1401. ———. 1981. Speech and Survival: Tradeoffs Between Quality and Quantity of Life in Laryngeal Cancer. New England Journal of Medicine 305:982–987. Mehrez, Abraham, and Amiriam Gafni. 1990. Evaluating Health Related Quality of Life: An Indifference Curve Interpretation for the Time Trade-Off Technique. Social Science and Medicine 31:1281–1283. ———. 1991. The Healthy-Years Equivalents: How to Measure Them Using the Standard Gamble Approach. Medical Decision Making 11:140–146. Menzel, Paul. 1999. How Should What Economists Call “Social Values” Be Measured? Journal of Ethics 3:249–273. Menzel, Paul, Marthe R. Gold, Erik Nord, Jose-Louis Pinto-Prades, et al. 1999. Toward A Broader View of Values in Cost-Effectiveness Analysis of Health. Hastings Center Report 29(3):7–15. Meyers, Allan R., and Elena M. Andresen. 2000. Enabling Our Instruments: Accomodation, Universal Design, and Access to Participation in Research. Archives of Physical Medicine and Rehabilitation 81(Suppl 2):S5–S9. Miller, Ted, J. Viner, S. Rossman, N. Pindus, et al. 1991. The Cost of Highway Crashes. Washington, DC: Urban Institute. Mishan, E.J. 1971. Cost–Benefit Analysis: An Informal Introduction. London: Allen and Unwin. ———. 1988. Cost–Benefit Analysis. 4th ed. London: Unwin Hyman. Mitchell, Robert C., and Richard T. Carson. 1989. Using Surveys to Value Public Goods: The Contingent Valuation Method. Washington, DC: Resources for the Future. Miyamoto, John M., and Stephen A. Eraker. 1985. Parameter Estimates for a QALY Utility Model. Medical Decision Making 5(2):191–213. ———. 1988. A Multiplicative Model of the Utility of Survival Duration and Health Quality. Journal of Experimental Psychology: General 117(1):3–20. Molzahn, A.E., H.C. Northcott, and L. Hayduk. 1996. Quality of Life of Patients With End Stage Renal Disease: A Structural Equation Model. Quality of Life Research 5:426–432. Morgan, M. Granger, and Max Henrion. 1990. Uncertainty: A Guide to Dealing With Uncertainty in Quantitative Risk and Policy Analysis. New York: Cambridge University Press. Moriarty, David. 2004 (December 1). Tracking Health-Related Quality of Life in the United States, 1993–2004. Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Morrall, John, III. 1986. A Review of the Record. Regulation 10:25–34. ———. 2003. Saving Lives: A Review of the Record. Working Paper 03-06. Washington, DC: AEI-Brookings Joint Center for Regulatory Studies. Murray, Christopher J.L., and Arnab K. Acharya. 1997. Understanding DALYs. Journal of Health Economics 16:703–730. Murray, Christopher J.L., and Alan D. Lopez, eds. 1996. The Global Burden of Disease. Washington, DC: World Health Organization. Najman, J.M., and S. Levine. 1981. Evaluating the Impact of Medical Care and Technologies on the Quality of Life: A Review and Critique. Social Science and Medicine 15:107–115. National Center for Health Statistics (NCHS). 2004. Health, United States, 2004: With Chartbook on Trends in the Health of Americans. Hyattsville, MD: U.S. Government Printing Office. Department of Health and Human Services. ———. 2005. 2004 National Health Interview Survey (NHIS) Public Use Data Release: NHIS Survey Description. Hyattsville, MD: NCHS and Centers for Disease Control and Prevention. Department of Health and Human Services.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis National Highway Traffic Safety Administration (NHTSA). 1996. The Economic Cost of Motor Vehicle Crashes, 1994. DOT-HS-808-425. Washington, DC: National Highway Traffic Safety Administration. ———. 1999a. Final Economic Assessment: FMVCSS No. 213, FMVSS No. 225, Child Restraint Systems; Child Restraint Anchorage Systems. Washington, DC: Office of Regulatory Analysis. ———. 1999b. Federal Motor Vehicle Safety Standards; Child Restraint Anchorage Systems; Final Rule. Federal Register 64(43):10786–10850. ———. 2002a. The Economic Impact of Motor Vehicle Crashes, 2000. DOT-HS-809-446. Washington, DC: National Highway Traffic Safety Administration. ———. 2002b. National Automotive Sampling System (NASS) Crashworthiness Data System, Analytical User’s Manual, 2002 File. Washington, DC: National Center for Statistics and Analysis. National Research Council (NRC). 2002. Estimating the Public Health Benefits of Proposed Air Pollution Regulations. Washington, DC: National Academy Press. Neumann, Peter J. 2005. Using Cost-Effectiveness Analysis to Improve Health Care: Opportunities and Barriers. New York: Oxford University Press. Neumann, Peter J., Patricia W. Stone, Richard H. Chapman, Eileen A. Sandberg, and Chaim M. Bell. 2000. The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997. Annals of Internal Medicine 132(12):964–972. Nichol, Michael B., Nishan Sengupta, and Denise R. Globe. 2001. Evaluating Quality-Adjusted Life Years: Estimation of the Health Utility Index (HUI2) From the SF-36. Medical Decision Making 21(2):105–112. Nord, Erik. 1992. An Alternative to QALYs: The Saved Young Life Equivalent (SAVE). British Medical Journal 305:875–877. ———. 1999. Cost-Value Analysis in Health Care: Making Sense Out of QALYs. Cambridge: Cambridge University Press. ———. 2001. The Desirability of a Condition Versus the Well Being and Worth of a Person. Health Economics 10:579–581. Nord, Erik, Jose L. Pinto, Jeff Richardson, Paul Menzel, and Peter Ubel. 1999. Incorporating Societal Concerns for Fairness in Numerical Valuations of Health Programmes. Health Economics 8:25–39. O’Brien, Bernie, and J.L. Viramontes. 1994. Willingness to Pay: A Valid and Reliable Measure of Health State Preference? Medical Decision Making 14(3):289–297. O’Connor, A.M., and R.A. Pennie. 1995. Reliability and Validity of Measures Used to Elicit Health Expectations, Values, Tradeoffs and Intentions to be Immunized for Hepatitis B. Journal of Clinical Epidemiology 48(2):255–262. Oostenbrink, Jan B., Marco J.D. Tangelder, Jan J.V. Busschbach, et al. 2001. Cost-Effectiveness of Oral Anticoagulants Versus Aspirin in Patients After Infrainguinal Pass Grafting Surgery. Journal of Vascular Surgery 34:254–262. Parker, Richard W. 2003. Grading the Government. University of Chicago Law Review 70:1345–1373. Patrick, Donald L., and Yen-Pin Chiang. 2000. Measurement of Health Outcomes in Treatment Effectiveness Evaluations. Medical Care 38(9 Suppl II):II-14–II-25. Patrick, Donald L., and Pennifer Erickson. 1993. Health Status and Health Policy: Allocating Resources to Health Care. New York: Oxford University Press. Patrick, Donald L., J.W. Bush, and M.M. Chen. 1973. Methods for Measuring Levels of Well-Being for a Health Status Index. Health Services Research 8:228–245. Payne, John W., James R. Bettman, and David A. Schkade. 1999. Measuring Constructed Preferences: Towards a Building Code. Journal of Risk and Uncertainty 19(1–3):243–270.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Peters, Annette, Douglas W. Dockery, James E. Muller, and Murray A. Mittleman. 2001. Increased Particulate Air Pollution and the Triggering of Myocardial Infarction. Circulation 103:2810–2815. Petrou, Stavros. 2003. Methodological Issues Raised by Preference-Based Approaches to Measuring the Health Status of Children. Health Economics 12:697–702. Phelps, Charles E., and Alvin J. Mushlin. 1991. On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analysis. International Journal of Technology Assessment in Health Care 7(1):12–21. Pickard, A.S., and Sara J. Knight. 2005. Proxy Evaluation of Health-Related Quality of Life: A Conceptual Framework for Understanding Multiple Proxy Perspectives. Medical Care 43(5):493–499. Pliskin, Joseph S., Donald Shepard, and Milton C. Weinstein. 1980. Utility Functions for Life Years and Health Status. Operations Research 28:206–224. Pope, C. Arden, III, Richard T. Burnett, Richard J. Thun, Eugenia E. Calle, et al. 2002. Lung Cancer, Cardiopulmonary Mortality, and Long-Term Exposure to Fine Particulate Air Pollution. Journal of the American Medical Association 287(9):1137–1141. Portney, Paul R., and John P. Weyant, eds. 1999. Discounting and Intergenerational Equity. Washington, DC: Resources for the Future. Rawls, John. 1971. A Theory of Justice. Cambridge, MA: Harvard University Press. ———. 1993. Political Liberalism. New York: Columbia University Press. Reagan, Ronald. 1981 (February 17). Federal Regulation, Executive Order 12291. White House. Reed, W.W., J.E. Herbers, and G.L. Noel. 1993. Cholesterol Lowering Therapy: What Patients Expect in Return. Journal of General Internal Medicine 8:591–596. Revesz, Richard L. 1999. Environmental Regulation, Cost-Benefit Analysis, and the Discounting of Human Lives. Columbia Law Review 99(4):941–1017. Revicki, Dennis A. 1992. Relationship Between Health Utility and Psychometric Health Status Measures. Medical Care 30(5 Suppl):MS274–MS282. Richardson, Jeff, and Erik Nord. 1997. The Importance of Perspective in the Measurement of Quality-Adjusted Life Years. Medical Decision Making 17:33–41. Riis, Jason, George Loewenstein, Jonathan Baron, Christopher Jepson, et al. 2005. Ignorance of Hedonic Adaptation to Hemo-Dialysis: A Study Using Ecological Momentary Assessment. Journal of Experimental Psychology: General 134(1):3–9. Rizzo, J.A., S. Pashko, R. Friedkin, J. Mullahy, and J.L. Sindelar. 1998. Linking the Health Utilities Index to National Medical Expenditure Survey Data. Pharmacoeconomics 13(5): 531–541. Rizzo, John A., and Jody L. Sindelar. 1999. Linking Health-Related Quality-of-Life Indicators to Large National Data Sets. Pharmacoeconomics 16(5 Pt 1):473–482. Robinson, Lisa A. 2004. Current Federal Agency Practices for Valuing the Impact of Regulations on Human Health and Safety. Prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Robinson, Lisa A., Phaedra Corso, Xiangming Fang, Robert Black, and Wilhelmine Miller. 2005a. Alternative Approaches for Estimating Health-Related Quality of Life Impact: Child Restraints Case Study. Prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Robinson, Lisa A., Wilhelmine Miller, and Robert Black. 2005b. Alternative Approaches for Estimating Health-Related Quality of Life Impact: Juice Processing Regulation Case Study. Prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis ———. 2005c. Alternative Approaches for Estimating Health-Related Quality of Life Impact: Nonroad Engine Air Emissions Regulation Case Study. Prepared for the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Rothman, Margaret L., Susan C. Hedrick, Kris A. Bulcroft, et al. 1991. The Validity of Proxy-Generated Scores as Measures of Patient Health Status. Medical Care 29(2):115–124. Sackett, David L., and George W. Torrance. 1978. The Utility of Different Health States as Perceived by the General Public. Journal of Chronic Diseases 31:697–704. Salomon, Joshua A. 2003. Reconsidering the Use of Rankings in the Valuation of Health States: A Model for Estimating Cardinal Values From Ordinal Data. Population Health Metrics 1:1–12. Salomon, Joshua A., and Christopher C.L. Murray. 2004. A Multi-Method Approach to Measuring Health-State Valuations. Health Economics 13:281–290. Scharff, Robert L., and Amber Jessup. 2001. Valuing Chronic Disease for Heterogeneous Populations: The Case of Arthritis. Unpublished manuscript. College Park, MD: FDA. Schelling, Thomas. 1968. The Life You Save May Be Your Own. In: Chase, S., Jr., ed. Problems in Public Expenditure Analysis. Washington, DC: Brookings Institution. Shaw, James W., Jeffrey A. Johnson, and Stephen J. Coons. 2005. U.S. Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model. Medical Care 43(3):203–220. Silvers, Anita. 1996. (In) Equality, (Ab) Normality and the Americans With Disabilities Act. Journal of Medicine and Philosophy 21:209–224. Skrzycki, Cindy. 2003. Under Fire, EPA Drops the “Senior Death Discount.” [Online]. Available: http://www.rff.org/rff/news/coverage/2003/may/under-fire-epa-drops-the-seniordeath-discount.cfm [accessed July 28, 2005]. Slevin, M.L., L. Stubbs, H.J. Plant, et al. 1990. Attitudes to Chemotherapy: Comparing the Views of Patients With Cancer With Those of Doctors, Nurses and the General Public. British Medical Journal 300:1458–1460. Slovic, Paul. 2000. The Perception of Risk. London: Earthscan Publications. Slovic, Paul, Baruch Fischhoff, and Sarah Lichtenstein. 2000. Facts and Fears: Understanding Perceived Risk. In: Slovic, Paul. The Perception of Risk. London: Earthscan Publications. Pp. 137–153. Slovic, Paul, Melissa L. Finucane, Ellen Peters, and Donald G. MacGregor. 2004. Risk as Analysis and Risk as Feelings: Some Thoughts about Affect, Reason, Risk, and Rationality. Risk Analysis 24(2): 311–322. Smith, Noel, Sue Middleton, Kate Ashton-Brooks, et al. 2004. Disabled People’s Cost of Living: More Than You Would Think. York, UK: Joseph Rowntree Foundation. Smith, V. Kerry, George V. Houtven, and Subhrendu K. Pattanayak. 2002. Benefit Transfer Via Preference Calibration: “Prudential Algebra” for Policy. Land Economics 78(1):132–152. Smith, V. Kerry, Subhrendu K. Pattanayak, and George L. Van Houtven. 2003. Preference Calibration With QALYs. [Online]. Available: http://pubdevelopment.rti.org/www/pubs/pref_calib_QALYs.pdf [accessed August 15, 2005]. Stewart, Susan T., Rebecca M. Woodward, and David M. Cutler. 2005. A Proposed Method for Monitoring U.S. Population Health: Linking Symptoms, Impairments, Chronic Conditions, and Health Ratings. NBER Working Paper 11358. Cambridge, MA: National Bureau of Economic Research. Sullivan, Patrick W., William F. Lawrence, and Vahram Ghushchyan. 2005. A National Catalog of Preference-Based Scores for Chronic Conditions in the United States. Medical Care 43(7):736–749.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Sunstein, Cass R. 1996. Health-Health Tradeoffs. University of Chicago Law Review 63: 1533–1571. Sunstein, Cass R., and Arden Rowell. 2005. On Discounting Regulatory Benefits: Risk, Money, and Intergenerational Equity. Working Paper 05-08. Washington, DC: AEI-Brookings Joint Center for Regulatory Studies. Tengs, Tammy O. 2004. Cost-Effectiveness Versus Cost-Utility Analysis of Interventions for Cancer: Does Adjusting for Health-Related Quality of Life Really Matter? Value in Health 7(1):70–78. Tengs, Tammy O., and Ting H. Lin. 2003. A Meta-Analysis of Quality-of-Life Estimates for Stroke. Pharmacoeconomics 21(3):191–200. Tengs, Tammy O., Miriam E. Adams, Joseph S. Pliskin, Dana G. Safran, Joanna E. Siegel, et al. 1995. Five-Hundred Life-Saving Interventions and Their Cost-Effectiveness. Risk Analysis 15(3):369–390. Tengs, Tammy O., Michelle Yu, and Elvina Luistro. 2001. Health-Related Quality of Life After Stroke: A Comprehensive Review. Stroke 32:964–972. Torrance, George, Valery Walker, Ronald Grossman, and Jayanti Mukherjee. 1999. Economic Evaluation of Ciprofloxcin Compared With Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 year. Pharmacoeconomics 16(5 Pt 1):499–520. Torrance, George W. 1976. Social Preferences for Health States: An Empirical Evaluation of Three Measurement Techniques. Socio-Economic Planning Sciences 10:129–136. Torrance, George W., David L. Sackett, and Warren H. Thomas. 1973. Utility Maximization Model for Program Evaluation: A Demonstration Application. In: Berg, Richard L., ed. Health Status Indexes. Chicago: Hospital Research and Educational Trust. Pp. 156–164. Torrance, George W., Michael H. Boyle, and Sargent P. Horwood. 1982. Applications of Multi-Attribute Theory to Measure Social Preferences for Health States. Operations Research 30(6):1043–1069. Torrance, George W., William Furlong, David Feeny, and Michael Boyle. 1995. Multi-Attribute Preference Functions: Health Utilities Index. Pharmacoeconomics 7(6):503–520. Torrance, George W., David H. Feeny, William J. Furlong, Ronald D. Barr, et al. 1996. Multiattribute Utility Function for a Comprehensive Health Status Classification System: Health Utilities Index Mark 2. Medical Care 34(7):702–722. Treasury, H.M. 2005. Managing Risks to the Public: Appraisal Guidance. London: Controller of Her Majesty’s Stationery Office. Ubel, Peter A., Michael L. DeKay, Jonathan Baron, and David A. Asch. 1996. Cost-Effectiveness Analysis in a Setting of Budget Constraints. New England Journal of Medicine 334(18):1174–1177. Ubel, Peter A., George Loewenstein, Dennis Scanlon, and Mark Kamlet. 1998. Value Measurement in Cost-Utility Analysis: Explaining the Discrepancy Rating Scale and Person Trade-Off Elicitations. Health Policy 43:33–44. Ubel, Peter A., Jeff Richardson, and Paul Menzel. 2000. Societal Value, The Person Trade-Off, and the Dilemma of Whose Values to Measure for Cost-Effectiveness Analysis. Health Economics 9:127–136. U.S. Environmental Protection Agency (EPA). 1997. Final Report to Congress on the Benefits and Costs of the Clean Air Act, 1970 to 1990. EPA-410-R-97-002. Washington, DC: EPA. ———. 1999. Final Report to Congress on the Benefits and Costs of the Clean Air Act, 1990 to 2010. EPA-410-R-99-00. Washington, DC: EPA. ———. 2000a. Guidelines for Preparing Economic Analyses. EPA 240-R-00-003. Washington, DC: EPA. ———. 2000b. Valuing Fatal Cancer Risk Reductions. Washington, DC: EPA.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis ———. 2003. Regulations: A Vital Tool for Protecting Public Health and the Environment. Washington, DC: EPA. ———. 2004a. Control of Emissions of Air Pollution From Nonroad Diesel Engines and Fuel: Final Rule. Federal Register 69(124):38957–39273. ———. 2004b. Final Regulatory Impact Analysis: Control of Emissions From Nonroad Diesel Engines. EPA 420-R-04-07. Washington, DC: EPA. ———. 2005a. Regulatory Impact Analysis for the Final Clean Air Interstate Rule. EPA-452/R-05-002. Washington, DC: EPA. ———. 2005b. Valuing Time Losses Due to Illness. EPA 815-R-05-003. Washington, DC: EPA. U.S. Executive Office of the President (EOP). 1993. Executive Order 12866. Regulatory Planning and Review. As amended by Executive Order 13258 (2002). ———. 1994. Executive Order 12898. Federal Actions to Address Environmental Justice in Minority Populations and Low-Income Populations. As amended by Executive Order 12948 (1995). ———. 1997. Executive Order 13045. Protection of Children From Environmental Risks and Safety Risks. As amended by Executive Order 13299 (2001) and Executive Order 13296 (2003). ———. 2002. Ranking Regulatory Investments in Public Health. In: Fiscal Year 2003 Analytical Perspectives, Budget of the United States Government. Washington, DC: U.S. Government Printing Office. Pp. 419–421. U.S. Food and Drug Administration (FDA). 1998. Preliminary Regulatory Impact Analysis and Initial Regulatory Flexibility Analysis of the Proposed Rules to Ensure the Safety of Juice and Juice Products; Proposed Rule. Federal Register 63(84):24253–24378. ———. 2001. Hazard Analysis and Critical Control Point (HAACP); Procedures for the Safe and Sanitary Processing of Juice; Final Rule. Federal Register 66(13):6138–6202. U.S. Office of Management and Budget (OMB). 1997. Report to Congress on the Costs and Benefits of Federal Regulations. ———. 2000. Guidelines to Standardize Measures of Costs and Benefits and the Format of Accounting Statements (Memorandum M-00-08) . Washington, DC: Office of Management and Budget. ———. 2003a. Circular A-4, Regulatory Analysis. Washington, DC: Office of Management and Budget. ———. 2003b. Informing Regulatory Decisions: 2003 Report to Congress on the Costs and Benefits of Federal Regulations and Unfunded Mandates on State, Local, and Tribal Entities. Washington, DC: U.S. Office of Management and Budget. ———. 2004. Informing Regulatory Decisions: 2004 Draft Report to Congress on the Costs and Benefits of Regulations and Unfunded Mandates on State, Local, and Tribal Entities. Washington, DC: U.S. Office of Management and Budget. Viscusi, W. Kip, ed. 1994. The Mortality Costs of Regulatory Expenditures. Journal of Risk and Uncertainty 8(1):5–122. Viscusi, W. Kip, W.A. Magat, and A. Forrest. 1988. Altruistics and Private Values of Risk Reduction. Journal of Policy Analysis and Management 7(2):227–245. von Neumann, John, and Oscar Morgenstern. 1947. Theories of Games and Economic Behavior. Princeton, NJ: Princeton University Press. Walker, Rebecca L., and Andrew W. Siegel. 2002. Morality and the Limits of Societal Values in Health Care Allocation. Health Economics 11:265–273. Wang, Caroline. 1992. Culture, Meaning and Disability: Injury Prevention Campaigns and the Production of Stigma. Social Science and Medicine 35(9):1093–1102. Ware, John E., Jr. 2000. SF-36 Health Survey Update. Spine 25(24):3130–3139.

OCR for page 335
Valuing Health for Regulatory Cost-Effectiveness Analysis Wasserman, David, and Arlene Asch. 2004 (November 30). Mending, Not Ending CEA. Presentation to the Institute of Medicine Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation. Weinstein, Milton C., and William B. Stason. 1977. Foundations of Cost-Effectiveness Analysis for Health and Medical Practices. New England Journal of Medicine 296(13):716–721. Weinstein, Milton C., Pamela G. Coxson, Lawrence W. Williams, Theodore M. Pass, et al. 1987. Forecasting Coronary Heart Disease Incidence, Mortality, and Cost: The Coronary Heart Disease Policy Model. American Journal of Public Health 77(11):1417–1426. Weitzman, Martin L. 1999. Just Keep Discounting, But … In: Portney, Paul R., and Weyant, John P., eds. Discounting and Intergeneration Equity. Washington, DC: Resources of the Future. Pp. 23–29. Wildavsky, Aaron. 1980. Richer is Safer. The Public Interest 60:23–39. Willan, Andrew R., and Bernie J. O’Brien. 1996. Confidence Intervals for Cost-Effectiveness Ratios: An Application of Fieller’s Theorem. Health Economics 5(4):297–305. Williams, Alan. 1995. The Role of the EuroQoL Instrument in QALY Calculations. York, England: Centre for Health Economics. ———. 1997. Intergenerational Equity: An Exploration of the “Fair Innings” Argument. Health Economics 6:117–132. Wilson, Timothy D., Jay Meyers, and Daniel T. Gilbert. 2001. Lessons From the Past: Do People Learn From Experience That Emotional Reactions Are Short-Lived? Personality and Social Psychology Bulletin 27(12):1648–1661.